References
Greene JA, Paul WO, Fallier AE: The action of theophylline with ethylene diamine on intrathecal and venous pressures in cardiac failure and on bronchial obstruction in cardiac failure and in bronchial asthma. J Am Med Assoc 109:1712, 1937
Herrmann GR, Aynesworth MB, Marlin J: Successful treatment of persistent extreme dyspnea, status asthmaticus: Use of theophylline ethylene diamine (aminophylline USP). J Lab Clin Med 23:135, 1937
May CD: History of the introduction of theophylline into the treatment of asthma. Clin Allergy 4:211–217, 1974
Ellis EF: Theophylline and derivatives, in Middleton E Jr, Reed CE, Ellis EF (eds): Allergy: Principles and Practice, St. Louis, CV Mosby, 1978, pp 434–453
Armand J, Deplante D, Badinand A: Theophylline toxicity in children. Lyon Med 229:485, 1973
Ogilvie RI: Clinical pharmacokinetics of theophylline. Clin Pharmacol 3:267, 1978
Weinberger M, Hendeles L, Ahrens R: Clinical pharmacology of drugs used for asthma. Pediatr Clin North Am 28:47–75, 1981
Weinberger M, Hendeles L, Bighley L: The relation of product formulation to absorption of oral theophylline. N Engl J Med 299:852–857, 1978
Kampa IS, Dunikoski LK Jr, Jarzabek JI, Grubesich D: Comparison of three assay procedures for theophylline determination. Ther Drug Monit 1:249–256, 1979
Boeck RL, Frith EM, Simons FER: Comparison of a high performance liquid chromatographic and an enzyme immunoassay technique for quantitation of theophylline in serum. Ther Drug Monit 1:65–73, 1979
Cornish HH, Christman AA: A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem 228:315–323, 1957
Ellis EF, Koysooko R, Levy G: Pharmacokinetics of theophylline in children with asthma. Pediatrics 58:542–547, 1976
Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup, JR, Vance JW: Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci 68:1358–1366, 1979
Gal P, Jusko WJ, Yurchak AM, Franklin BA: Theophylline disposition in obesity. Clin Pharmacol Ther 23:438–444, 1978
Blouin RA, Elgert JF, Bauer LA: Theophylline clearance: Effect of marked obesity. Clin Pharmacol Ther 28:619–623, 1980
Monks TJ, Caldwell J, Smith RL: Influence of methylxanthine-containing foods on theophylline metabolism and kinetics. Clin Pharmacol Ther 26:513–524, 1979
Kappas A, Anderson KE, Conney AH, Alvares AP: Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin Pharmacol Ther 20:643–653, 1976
Kappas A, Alvares AP, Anderson KE, Pantuck EJ, Pantuck CB, Chang R, Conney AH: Effect of charcoal-broiled meat on antipyrine and theophylline metabolism. Clin Pharmacol Ther 23:445–450, 1978
Jusko WJ, Scentag JJ, Clark JH, Gardner M, Yurchak AM: Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clin Pharmacol Ther 24:406–410, 1978
Grygiel JJ, Birkett DJ: Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther 30:491–196, 1981
Powell JR, Thiercelin J-F, Vozeh S, Sansom L, Reigelman S: The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis 116:17–23, 1977
Marquis J, Carruthers SG, Spence JD, Brownstone YS, Toogood JH: Phenytoin-theophylline interaction. N Engl J Med 307:1189, 1982
Weinberger M, Hudgel D, Spector S, Chidsey C: Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol 59:228–231, 1977
LaForce CF, Miller MF, Chai H: Effect of erythromycin on theophylline clearance in asthmatic children. J Pediatr 99:153–156, 1981
Prince RA, Wing DS, Weinberger MM, Hendeles LS, Riegelman S: Effect of erythromycin on theophylline kinetics. J Allergy Clin Immunol 68:427–431, 1981
Zarowitz BJM, Szefler SJ, Lasezkay GM: Effect of erythromycin base on theophylline kinetics. Clin Pharmacol Ther 29:601–605, 1981
Jackson JE, Powell JR, Wandell M, Bently J, Dorr R: Cimetidine decreases theophylline clearance. Am Rev Respir Dis 123:615–617, 1981
Roberts RK, Grice J, Wood L, Petroff V, McGuffie C: Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81:19–21, 1981
Weinberger M, Smith G, Milavetz G, Hendeles L: Decreased theophylline clearance due to cimetidine. N Engl J Med 304:672, 1981
Conrad KA, Nyman DW: Effects of metoprolol and propranolol on theophylline elimination. Clin Pharmacol Ther 28:463–167, 1980
Renton KW, Gray JD, Hall RI: Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 123:288–290, 1980
Mangione A, Imhoff TE, Lee RV, Shum LY, Jusko WJ: Pharmacokinetics of theophylline in hepatic disease. Chest 73:616–622, 1978
Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI: Theophylline disposition in patients with hepatic cirrhosis. N Engl J Med 296:1495–1497, 1977
Jenne JW, Chick TW, Miller BA, Strickland RD: Apparent theophylline half-life fluctuations during treatment of acute left ventricular failure. Am J Hosp Pharm 34:408–409, 1977
Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI: Theophylline kinetics in acute pulmonary edema. Clin Pharmacol Ther 21:310–316, 1977
Vicuna N, McNay JL, Ludden TM, Schwertner H: Impaired theophylline clearance in patients with cor pulmonale. Br J Clin Pharmacol 7:33–37, 1979
Chang KC, Bell TD, Lauer BA, Chai H: Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 1:1132–1133, 1978
Vozeh S, Powell JR, Riegelman S, Costello JF, Sheiner LB, Hopewell PC: Changes in theophylline clearance during acute illness. J Am Med Assoc 240:1882–1884, 1978
Weinberger M, Ginchansky E: Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr 91:820–824, 1977
Jenne JW, Wyze MS, Rood FS: Pharmacokinetics of theophylline: Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 13:349, 1972
Sarrazin E, Hendeles L, Weinberger M, Muir K, Riegelman S: Dose-dependent kinetics for theophylline: Observations among ambulatory asthmatic children. J Pediatr 97:825–828,1980
Eney RD, Goldstein EO: Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Pediatrics 57:513–517, 1976
Sublett JL, Pollard SJ, Kadlec GJ, Karibo JM: Non-compliance in asthmatic children: A study of theophylline levels in a pediatric emergency room population. Ann Allergy 43:95–97, 1979
Green ER, Green AW, Lane R, Slaughter R, Middleton E Jr: Absorption characteristics of sustained release theophylline capsules administered in applesauce. J Pediatr 98:832–834, 1981
Weinberger M, Hendeles L, Wong I, Vaughan L: Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma. J Pediatr 99:145–152, 1981
Simons FER, Luciuk GH, Simons KJ: Sustained-release theophylline for treatment of asthma in preschool children. Am J Dis Child 136:790–793, 1982
Dederich RA, Szefler SJ, Green ER: Intrasubject variation in sustained-release theophylline absorption. J Allergy Clin Immunol 67:465–471, 1981
Mitenko PA, Ogilvie RI: Rational intravenous doses of theophylline. N Engl J Med 289:600–603, 1973
Maselli R, Casal GL, Ellis EF: Pharmacologic effects of intravenously administered aminophylline in asthmatic children. J Pediatr 76:777–782, 1970
Nicholson DP, Chick TW: A re-evaluation of parenteral aminophylline. Am Rev Respir Dis 108:241–247, 1973
Rachelefsky GS, Katz RM, Siegel SC: A sustained release theophylline preparation: Efficacy in childhood asthma with low serum theophylline levels. Ann Allergy 40:252–257, 1978
Ogilvie RI: Monitoring plasma theophylline concentrations. Ther Drug Monit 2:111–117,1980
Hendeles L, Weinberger M, Johnson G: Monitoring serum theophylline levels. Clin Pharmacokinet 3:294–312, 1978
Koysooko R, Ellis EF, Levy G: Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther 15:454–460, 1974
Jonkman JHG, Koeter GH, Schoenmaker R, deVries K, Greving JE, deZeeuw RA: Correlation of serum and saliva theophylline concentrations after administration of a sustained release preparation. Eur J Clin Pharmacol 20:73–78, 1981
Leung P, Kalisker A, Bell TD: Variation in theophylline clearance rate with time in chronic childhood asthma. J Allergy Clin Immunol 59:440–444, 1977
Nicklas RA, Whitehurst VE, Donohoe RF: Combined use of beta-adrenergic agonists and methyl xanthines. N Engl J Med 307:557–558, 1982
Snodgrass W, Sawyer D, Conner CS, Rumack BH, Peterson RG, Sullivan, Jr., JB: Asymptomatic theophylline overdose. Drug Intell Clin Pharm 14:783–785, 1980
Sintek C, Hendeles L, Weinberger M: Inhibition of theophylline absorption by activated charcoal. J Pediatr 94:314–316, 1979
Berg MJ, Berlinger WG, Goldberg MJ, Spector R, Johnson GF: Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med 307:642–644, 1982
Espinosa-Melendez E, Chang TMS: ACAC (albumin-collodion coated activated charcoal) hemoperfusion: In-vitro removal and clearance of theophylline. J Dial 4:21–29, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ellis, E.F. Theophylline. Clin Rev Allerg 1, 73–85 (1983). https://doi.org/10.1007/BF02991318
Issue Date:
DOI: https://doi.org/10.1007/BF02991318